[Peptides--inhibitors of carboxycathepsin (peptidyl-dipeptidase A) and their role in clinical medicine].
Properties of the carboxycathepsin inhibitors teprotide, captopryl, enalacryl are considered. Presence of low molecular thermo- and acid stable carboxycathepsin inhibitors of peptide nature in blood serum and lymphocytes is discussed.
D015097:3-Mercaptopropionic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D000804:Angiotensin II / Q000378:metabolism*; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D001920:Bradykinin / Q000378:metabolism*; D002216:Captopril / Q000494:pharmacology; D004285:Dogs; D006801:Humans; D007703:Peptidyl-Dipeptidase A / Q000502:physiology; D013582:Synovial Fluid / Q000201:enzymology; D013722:Teprotide / Q000494:pharmacology; D053778:Thiazolidines
D000806:Angiotensin-Converting Enzyme Inhibitors; D053778:Thiazolidines; D000804:Angiotensin II; C019135:(4R)-3-((2S)-3-mercapto-2-methylpropanoyl)-4- thiazolidinecarboxylic acid; D002216:Captopril; D015097:3-Mercaptopropionic Acid; D013722:Teprotide; C033437:rentiapril; D007703:Peptidyl-Dipeptidase A; D001920:Bradykinin
Peptidy-ingibitory karpoksikatepsina (peptidil-dipeptidazy A) i ikh znachenie dlia klinicheskoĭ meditsiny.